non-small cell lung cancer (NSCLC)
Conditions
Interventions
Sponsors
First Hospital of China Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patient age should be 18 years or above, and both males and females are eligible; 2. Diagnosed with non-small cell lung cancer by histological/cytological examination; 3. At least one measurable lesion that meets the RECIST 1.1 criteria; 4. Clinically evaluated as suitable for immunotherapy with immune checkpoint inhibitors; 5. Expected survival period >= 6 months; 6. Eastern Cooperative Oncology Group (ECOG) performance status score of 0-1; 7. Adequate organ and tissue functions; 8. Willing and able to follow the planned visits, research treatments, laboratory tests, and other trial procedures; 9. No history of other malignant tumors in the past.
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women; 2. In the judgment of the clinical physician, complications or other diseases make the patient unsuitable to participate in this study; 3. Patients with other serious physical or mental diseases or abnormal laboratory test results, which may increase the risk of participating in the study or interfere with the research results, as well as patients that the researcher considers unsuitable to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression Free Survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall Survival; | — |
Countries
China
Contacts
Public ContactXiujuan Qu
First Hospital of China Medical University
Outcome results
None listed